MIGLITOL

MIGLITOL: Miglitol is an oral medication that is primarily used to treat type 2 diabetes mellitus. It belongs to the class of drugs known as alpha-glucosidase inhibitors.

Miglitol works by inhibiting the enzymes in the small intestine responsible for breaking down carbohydrates into simple sugars. This slows down the digestion and absorption of carbohydrates, leading to a slower and more controlled increase in blood sugar levels after meals.

The recommended starting dose of miglitol is usually 25 mg taken orally three times a day, with the first bite of each main meal. The dose can be increased to a maximum of 100 mg three times a day, depending on the patient’s response and blood sugar levels. It is important to take miglitol with meals, as it works by specifically targeting the digestion of carbohydrates.

Common side effects of miglitol include abdominal pain, diarrhea, flatulence, and bloating. These side effects are generally mild and transient, and usually improve with continued use of the drug. However, if the side effects persist or become severe, it is important to consult a healthcare professional.

Miglitol should not be used in individuals with kidney or liver disease, inflammatory bowel disease, or in patients with intestinal obstruction or chronic intestinal diseases associated with digestion or absorption disorders. It is also contraindicated in individuals with a known hypersensitivity to miglitol or any of its components.

As with any medication, it is important to discuss the use of miglitol with a healthcare professional before starting treatment, as they can provide personalized advice and monitor for potential drug interactions or contraindications.